NCT00021502View on ClinicalTrials.gov

Safety and Efficacy of PHP in the Treatment of Shock Associated With Systemic Inflammatory Response Syndrome (SIRS)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

August 31, 2003

Study Completion Date

May 31, 2004

Conditions
ShockSystemic Inflammatory Response Syndrome
Interventions
DRUG

pyridoxalated hemoglobin polyoxyethylene conjugate (PHP)

Sponsors

Lead Sponsor

Apex Bioscience
All Listed Sponsors
lead

Apex Bioscience

INDUSTRY

NCT00021502 - Safety and Efficacy of PHP in the Treatment of Shock Associated With Systemic Inflammatory Response Syndrome (SIRS) | Biotech Hunter | Biotech Hunter